In our experiments using a murine melanoma model, we applied a combined immunotherapeutic approach, LRAST, consisting of lymphodepletion with the alkylating agent cyclophosphamide, followed by i.v. reconstitution with naive congenic spleen cells and active-specific tumor vaccination using GM-CSF-secreting whole tumor cells. Here, CSF2 is linked to neoplasm.